No CDC Level 4 Travel Health Notice currently exists as of mid-May 2026, with all active alerts at Level 1 or 2 for dengue, polio, and measles. Official criteria demand an extreme health risk where no effective precautions exist, a threshold unmet by present transmission patterns or the low-level hantavirus activation. Ongoing Ebola outbreaks in the Democratic Republic of the Congo and Uganda have prompted CDC entry screening and a temporary Title 42 order, yet risk assessments still classify the general U.S. public threat as low. Trader consensus at 76% for “No” aligns with this stable surveillance data and historical precedent that even notable outbreaks rarely reach Level 4 absent novel high-risk developments. Summer and fall monitoring updates will serve as key checkpoints before year-end resolution.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourLe CDC émet un avertissement de niveau 4 d'ici le 31 décembre ?
Oui
$71,630 Vol.
$71,630 Vol.
Oui
$71,630 Vol.
$71,630 Vol.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Marché ouvert : Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...No CDC Level 4 Travel Health Notice currently exists as of mid-May 2026, with all active alerts at Level 1 or 2 for dengue, polio, and measles. Official criteria demand an extreme health risk where no effective precautions exist, a threshold unmet by present transmission patterns or the low-level hantavirus activation. Ongoing Ebola outbreaks in the Democratic Republic of the Congo and Uganda have prompted CDC entry screening and a temporary Title 42 order, yet risk assessments still classify the general U.S. public threat as low. Trader consensus at 76% for “No” aligns with this stable surveillance data and historical precedent that even notable outbreaks rarely reach Level 4 absent novel high-risk developments. Summer and fall monitoring updates will serve as key checkpoints before year-end resolution.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes